Piramal Pharma Limited
PPLPHARMA.NS

$3.39 B
Marketcap
$2.56
Share price
Country
$-0.15
Change (1 day)
$2.90
Year High
$1.04
Year Low
Categories

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

marketcap

Revenue of Piramal Pharma Limited (PPLPHARMA.NS)

Revenue in 2023 (TTM): $971.88 M

According to Piramal Pharma Limited's latest financial reports the company's current revenue (TTM) is $971.88 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Piramal Pharma Limited

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $971.88 M $291.06 M $142.28 M $14.25 M $2.12 M
2022 $842.28 M $520.75 M $107.96 M $-14,290,664 $-22,177,588
2021 $368.16 M $183.91 M $48.78 M $50.46 M $44.72 M
2020 $349.54 M $197.5 M $72.71 M $81.69 M $67.97 M